Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cerus initiates phase I trial of cancer drug
CRS-100 is a bacteria-based immune therapy that targets liver metastases. The primary objectives of the study are to determine the maximum tolerated dose and to explore the safety
CRS-100 is a bacteria-based immune therapy that targets liver metastases. The primary objectives of the study are to determine the maximum tolerated dose and to explore the safety
Researchers have found that the same gene mutation responsible for a tepid response to Gleevec, in treatment of GIST, bestows benefit when Pfizer's new targeted therapy, Sutent is
CV Therapeutics said it would finish the promotion of high blood pressure drug Aceon over the next few weeks. There are no financial commitments for either company related
The offer includes the acquisition of all outstanding shares of AnorMed to $13.50 per share, contingent upon AnorMed executing a support agreement with Genzyme. This proposal represents a
<p>On June 21, 2006, Belcher submitted its abbreviated new drug application filing with the FDA, and included a Paragraph IV certification under the Hatch-Waxman Act, certifying that Belcher
However, the positive effect of Omega-3 does not appear in cases with more advanced Alzheimer’s. Alzheimer’s disease is a severely debilitating condition that affects thinking, learning and memory,
NeuroVax is an investigational T-cell receptor (TCR) peptide vaccine. The company has secured two new partners for the launch of its phase II trial of Neurovax. NeuroRx Research
The FDA blocked Roche from selling the pumps in the US shortly after the company bought Desetronic Medical Systems, which specialized in insulin pumps. Roche bought the company
The study will evaluate M118, a next-generation anticoagulant designed specifically for use in treating patients diagnosed with acute coronary syndromes (ACS). M118 will also be tested for its
Malignant infantile osteopetrosis is a rare hereditary disorder of osteoclast function, which can be reversed by hematopoietic stem cell transplantation (SCT). The study noted that a high level